Cannabis controversies: How genetics can inform the study of comorbidity

Addiction

Volumn 109, Issue 3, 2014, Pages 360-370

  Agrawal, Arpana ^a   Lynskey, Michael T ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; Comorbidity; Gateway; Genetics; Psychosis; Twin

Indexed keywords

CANNABIS; STREET DRUG;

CANNABIS SMOKING; COMORBIDITY; DEPRESSIVE DISORDER; DIZYGOTIC TWINS; GENETIC PREDISPOSITION; GENETICS; HUMAN; MONOZYGOTIC TWINS; PSYCHOTIC DISORDERS; SOCIAL ENVIRONMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; SUICIDE;

CANNABIS; COMORBIDITY; DEPRESSIVE DISORDER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MARIJUANA SMOKING; PSYCHOTIC DISORDERS; SOCIAL ENVIRONMENT; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SUICIDE; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84893867657     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12436     Document Type: Review

References (109)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2013: trends and developments. Lisbon: EMCDDA; 2013.
2. Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future national results on adolescent drug use: overview of key findings, 2012. Ann Arbor: Institute for Social Research, The University of Michigan; 2013.
3. Australian Institute of Health and Welfare (AIHW). 2010 National Drug Strategy Household Survey Report. Report no.: Data statistics series no. 25. Cat. no. PHE 145. Canberra: AIHW; 2011.
4. Degenhardt L., Chiu W. T., Sampson N., Kessler R. C., Anthony J. C., Angermeyer M. etal. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLOS Med 2008; 5: e141.
5. Nutt D., King L. A., Saulsbury W., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 1047-1053.
6. Anthony J. C., Helzer J. E. Syndromes of drug abuse and dependence. In: Robins L. N., Regier D. A., editors. Psychiatric Disorders in America: The Epidemiological Catchment Area Study. New York: Free Press; 1991, pp. 116-154.
7. Asbridge M., Hayden J. A., Cartwright J. L. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344: e536.
8. Hartman R. L., Huestis M. A. Cannabis effects on driving skills. Clin Chem 2013; 59: 478-492.
9. Verweij K. J., Zietsch B. P., Lynskey M. T., Medland S. E., Neale M. C., Martin N. G. etal. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105: 417-430.
10. Agrawal A., Verweij K. J., Gillespie N. A., Heath A. C., Lessov-Schlaggar C. N., Martin N. G. etal. The genetics of addiction-a translational perspective. Transl Psychiatry 2012; 2: e140.
11. Fowler T., Lifford K., Shelton K., Rice F., Thapar A., Neale M. C. etal. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction 2007; 102: 413-422.
12. Rijsdijk F. V., Gottesman I. I., McGuffin P., Cardno A. G. Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 89-98.
13. Kendler K. S., Gardner C. O., Neale M. C., Prescott C. A. Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol Med 2001; 31: 605-616.
14. Statham D. J., Heath A. C., Madden P. A., Bucholz K. K., Bierut L., Dinwiddie S. H. etal. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998; 28: 839-855.
15. Rutter M., Moffitt T. E., Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006; 47: 226-261.
16. Plomin R., Koeppen-Schomerus G. Beyond heritability. Psychosom Med 2002; 64: 204-205.
17. Bookman E. B., McAllister K., Gillanders E., Wanke K., Balshaw D., Rutter J. etal. Gene-environment interplay in common complex diseases: forging an integrative model-recommendations from an NIH workshop. Genet Epidemiol 2011; 35: 217-225.
18. Bossong M. G., Jansma J. M., van Hell H. H., Jager G., Oudman E., Saliasi E. etal. Effects of delta9-tetrahydrocannabinol on human working memory function. Biol Psychiatry 2012; 71: 693-699.
19. Bossong M. G., Jager G., Bhattacharyya S., Allen P. Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies. Curr Pharm Des 2013; in press.
20. Kenkel D., Mathios A. D., Pacula R. L. Economics of youth drug use, addiction and gateway effects. Addiction 2001; 96: 151-164.
21. Khantzian E. J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259-1264.
22. Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493-1504.
23. Fergusson D. M., Horwood L. J., Lynskey M. T. The comorbidities of adolescent problem behaviors: a latent class model. J Abnorm Child Psychol 1994; 22: 339-354.
24. Hays R. D., Ellickson P. L. Associations between drug use and deviant behavior in teenagers. Addict Behav 1996; 21: 291-302.
25. Donovan J. E., Jessor R., Costa F. M. Adolescent health behavior and conventionality-unconventionality: an extension of problem-behavior theory. Health Psychol 1991; 10: 52-61.
26. Leventhal T., Brooks-Gunn J. The neighborhoods they live in: the effects of neighborhood residence on child and adolescent outcomes. Psychol Bull 2000; 126: 309-337.
27. Galea S., Ahern J., Tracy M., Vlahov D. Neighborhood income and income distribution and the use of cigarettes, alcohol, and marijuana. Am J Prev Med 2007; 32: S195-202.
28. Krueger R. F., Hicks B. M., Patrick C. J., Carlson S. R., Iacono W. G., McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J Abnorm Psychol 2002; 111: 411-424.
29. Hicks B. M., Schalet B. D., Malone S. M., Iacono W. G., McGue M. Psychometric and genetic architecture of substance use disorder and behavioral disinhibition measures for gene association studies. Behav Genet 2011; 41: 459-475.
30. Caspi A., Moffitt T. E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006; 7: 583-590.
31. Henquet C., Di F. M., Morrison P., Kuepper R., Murray R. M. Gene-environment interplay between cannabis and psychosis. Schizophr Bull 2008; 34: 1111-1121.
32. Caspi A., Moffitt T. E., Cannon M., McClay J., Murray R., Harrington H. etal. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol Psychiatry 2005; 57: 1117-1127.
33. Agrawal A., Lynskey M. Have the genetics of cannabis involvement gone to pot? 61st Annual Nebraska Symposium on Motivation. Springer; 2013, in press.
34. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M. etal. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579-1588.
35. Kendler K. S., Neale M. C., MacLean C. J., Heath A. C., Eaves L. J., Kessler R. C. Smoking and major depression. A causal analysis. Arch Gen Psychiatry 1993; 50: 36-43.
36. Lynskey M. T., Heath A. C., Bucholz K. K., Slutske W. S., Madden P. A., Nelson E. C. etal. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289: 427-433.
37. Neale M. C., Cardon L. R. Methodology for Genetic Studies of Twins and Families. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1992.
38. Kandel D. Stages in adolescent involvement in drug use. Science 1975; 190: 912-914.
39. Kandel D. B. Does marijuana use cause the use of other drugs? JAMA 2003; 289: 482-483.
40. Kandel D., Yamaguchi K. From beer to crack: developmental patterns of drug involvement. Am J Public Health 1993; 83: 851-855.
41. Fergusson D. M., Horwood L. J. Does cannabis use encourage other forms of illicit drug use? Addiction 2000; 95: 505-520.
42. Botvin G. J., Griffin K. W., Diaz T., Scheier L. M., Williams C., Epstein J. A. Preventing illicit drug use in adolescents: long-term follow-up data from a randomized control trial of a school population. Addict Behav 2000; 25: 769-774.
43. Ellgren M., Spano S. M., Hurd Y. L. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 2007; 32: 607-615.
44. Grant J. D., Lynskey M. T., Scherrer J. F., Agrawal A., Heath A. C., Bucholz K. K. A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use. Addict Behav 2010; 35: 35-41.
45. Lessem J. M., Hopfer C. J., Haberstick B. C., Timberlake D., Ehringer M. A., Smolen A. etal. Relationship between adolescent marijuana use and young adult illicit drug use. Behav Genet 2006; 36: 498-506.
46. Lynskey M., Vink J. M., Boomsma D. I. Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behav Genet 2006; 36: 195-200.
47. Agrawal A., Neale M. C., Prescott C. A., Kendler K. S. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med 2004; 34: 1227-1237.
48. Cleveland H. H., Wiebe R. P. Understanding the association between adolescent marijuana use and later serious drug use: gateway effect or developmental trajectory? Dev Psychopathol 2008; 20: 615-632.
49. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010; 36: 1115-1130.
50. Large M., Sharma S., Compton M. T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555-561.
51. Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-612.
52. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-1213.
53. Degenhardt L., Hall W. Cannabis and psychosis. Curr Psychiatry Rep 2002; 4: 191-196.
54. Degenhardt L., Hall W. Is cannabis use a contributory cause of psychosis? Can J Psychiatry 2006; 51: 556-565.
55. Macleod J., Davey S. G., Hickman M., Egger M. Cannabis and psychosis. Lancet 2007; 370: 1539-1540.
56. Manrique-Garcia E., Zammit S., Dalman C., Hemmingsson T., Andreasson S., Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med 2012; 42: 1321-1328.
57. Arseneault L., Cannon M., Witton J., Murray R. M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110-117.
58. Kuepper R., van Os J., Lieb R., Wittchen H. U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738. doi: 10.1136/bmj.d738.
59. Degenhardt L., Hall W., Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48.
60. Hickman M., Vickerman P., Macleod J., Lewis G., Zammit S., Kirkbride J. etal. If cannabis caused schizophrenia-how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction 2009; 104: 1856-1861.
61. Lachman H. M., Papolos D. F., Saito T., Yu Y. M., Szumlanski C. L., Weinshilboum R. M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
62. O'Tuathaigh C. M., Clarke G., Walsh J., Desbonnet L., Petit E., O'Leary C. etal. Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. Int J Neuropsychopharmacol 2012; 15: 1331-1342.
63. Zammit S., Owen M. J., Evans J., Heron J., Lewis G. Cannabis, COMT and psychotic experiences. Br J Psychiatry 2011; 199: 380-385.
64. Henquet C., Rosa A., Delespaul P., Papiol S., Fananas L., van Os J. etal. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand 2009; 119: 156-160.
65. Estrada G., Fatjo-Vilas M., Munoz M. J., Pulido G., Minano M. J., Toledo E. etal. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand 2011; 123: 485-492.
66. Alemany S., Arias B., Fatjo-Vilas M., Villa H., Moya J., Ibanez M. I. etal. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes. Acta Psychiatr Scand 2014; 129: 54-62.
67. Costas J., Sanjuan J., Ramos-Rios R., Paz E., Agra S., Tolosa A. etal. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res 2011; 127: 22-27.
68. Zammit S., Spurlock G., Williams H., Norton N., Williams N., O'Donovan M. C. etal. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br J Psychiatry 2007; 191: 402-407.
69. Lee S. H., Ripke S., Neale B. M., Faraone S. V., Purcell S. M., Perlis R. H. etal. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984-994.
70. Lev-Ran S., Roerecke M., Le F. B., George T. P., McKenzie K., Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2013; 24: 1-14.
71. Wittchen H. U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P. etal. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88: S60-70.
72. Horwood L. J., Fergusson D. M., Coffey C., Patton G. C., Tait R., Smart D. etal. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend 2012; 126: 369-378.
73. van Ours J. C., Williams J., Fergusson D., Horwood L. J. Cannabis use and suicidal ideation. J Health Econ 2013; 32: 524-537.
74. Price C., Hemmingsson T., Lewis G., Zammit S., Allebeck P. Cannabis and suicide: longitudinal study. Br J Psychiatry 2009; 195: 492-497.
75. Patton G. C., Coffey C., Carlin J. B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195-1198.
76. Fergusson D. M., Horwood L. J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123-1135.
77. Manrique-Garcia E., Zammit S., Dalman C., Hemmingsson T., Allebeck P. Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry 2012; 12: 112. doi: 10.1186/1471-244X-12-112.
78. Marmorstein N. R., Iacono W. G., McGue M. Associations between substance use disorders and major depression in parents and late adolescent-emerging adult offspring: an adoption study. Addiction 2012; 107: 1965-1973.
79. Fu Q., Heath A. C., Bucholz K. K., Nelson E., Goldberg J., Lyons M. J. etal. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Arch Gen Psychiatry 2002; 59: 1125-1132.
80. Lynskey M. T., Glowinski A. L., Todorov A. A., Bucholz K. K., Madden P. A., Nelson E. C. etal. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004; 61: 1026-1032.
81. Hill M. N., Gorzalka B. B. Impairments in endocannabinoid signaling and depressive illness. JAMA 2009; 301: 1165-1166.
82. Hill M. N., McLaughlin R. J., Bingham B., Shrestha L., Lee T. T., Gray J. M. etal. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci USA 2010; 107: 9406-9411.
83. Beyer C. E., Dwyer J. M., Piesla M. J., Platt B. J., Shen R., Rahman Z. etal. Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol Dis 2010; 39: 148-155.
84. Kintscher U. The cardiometabolic drug rimonabant: after 2 years of RIO-Europe and STRADIVARIUS. Eur Heart J 2008; 29: 1709-1710.
85. Stapleton J. A. Trial comes too late as psychiatric side effects end hope for rimonabant. Addiction 2009; 104: 277-278.
86. Juhasz G., Chase D., Pegg E., Downey D., Toth Z. G., Stones K. etal. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009; 34: 2019-2027.
87. Agrawal A., Nelson E. C., Littlefield A. K., Bucholz K. K., Degenhardt L., Henders A. K. etal. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Arch Gen Psychiatry 2012; 69: 732-740.
88. O'Brien M. S., Comment L. A., Liang K. Y., Anthony J. C. Does cannabis onset trigger cocaine onset? A case-crossover approach. Int J Methods Psychiatr Res 2012; 21: 66-75.
89. Anthony J. C. Steppingstone and gateway ideas: a discussion of origins, research challenges, and promising lines of research for the future. Drug Alcohol Depend 2012; 123: S99-104.
90. Kaminsky Z. A., Tang T., Wang S. C., Ptak C., Oh G. H., Wong A. H. etal. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009; 41: 240-245.
91. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010; 465: 721-727.
92. Tsankova N., Renthal W., Kumar A., Nestler E. J. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-367.
93. Wong C. C., Mill J., Fernandes C. Drugs and addiction: an introduction to epigenetics. Addiction 2011; 106: 480-489.
94. Renthal W., Nestler E. J. Epigenetic mechanisms in drug addiction. Trends Mol Med 2008; 14: 341-350.
95. Maze I., Nestler E. J. The epigenetic landscape of addiction. Ann NY Acad Sci 2011; 1216: 99-113. doi: 10.1111/j.1749-6632.2010.05893.x.
96. Nestler E. J. Epigenetic mechanisms of drug addiction. Neuropharmacology 2014; 76 Pt B: 259-268.
97. Mill J., Dempster E., Caspi A., Williams B., Moffitt T., Craig I. Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 421-425.
98. Ursini G., Bollati V., Fazio L., Porcelli A., Iacovelli L., Catalani A. etal. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J Neurosci 2011; 31: 6692-6698.
99. Davey S. G. Mendelian randomization for strengthening causal inference in observational studies: application to gene×environment interaction. Perspect Psychol Sci 2010; 5: 527-545.
100. Irons D. E., McGue M., Iacono W. G., Oetting W. S. Mendelian randomization: a novel test of the gateway hypothesis and models of gene-environment interplay. Dev Psychopathol 2007; 19: 1181-1195.
101. Verweij K. J., Zietsch B. P., Liu J. Z., Medland S. E., Lynskey M. T., Madden P. A. etal. No association of candidate genes with cannabis use in a large sample of Australian twin families. Addict Biol 2012; 17: 687-690.
102. Agrawal A., Lynskey M. T. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009; 104: 518-532.
103. Hutchison K. E., Haughey H., Niculescu M., Schacht J., Kaiser A., Stitzel J. etal. The incentive salience of alcohol: translating the effects of genetic variant in CNR1. Arch Gen Psychiatry 2008; 65: 841-850.
104. Han J., Kesner P., Metna-Laurent M., Duan T., Xu L., Georges F. etal. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 2012; 148: 1039-1050.
105. Hawken A., Caulkins J., Kilmer B., Kleiman M. Quasi-legal cannabis in Colorado and Washington: local and national implications. Addiction 2013; 108: 837-838.
106. Reuter P. Marijuana Legalization: What Can be Learned from Other Countries. Santa Monica, CA: RAND: Drug Policy Research Center; 2010. Available at: http://www.rand.org/content/dam/rand/pubs/working_papers/2010/RAND_WR771.pdf (accessed 26 December 2013) (Archived at http://www.webcitation.org/6MAQA7ToD).
107. Macleod J., Hickman M. Response to commentaries: moving towards an evidence-based policy around cannabis use. Addiction 2010; 105: 1337-1339.
108. Macleod J., Hickman M. How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do? Addiction 2010; 105: 1326-1330.
109. Hall W., Lynskey M. The challenges in developing a rational cannabis policy. Curr Opin Psychiatry 2009; 22: 258-262.